MiniMed Group, Inc. (MMED)
NASDAQ
Closed
Oct 8, 2026
Day's Range
18.9452 wk Range
10.65Overview - MMED - MiniMed Group, Inc.
Key Statistics
Valuation
Enterprise Value
5.39B
P/E (Trailing)
‪-15.16‬
P/E (Forward)
‪30.86‬
PEG Ratio
‪30.86‬
Price / Sales (TTM)
‪1.72‬
Price / Book
‪1.53‬
EV / EBITDA
‪18.86‬
Profitability
Gross Margin
‪55.16%‬
Profit Margin
‪-9.74%‬
Operating Margin
‪0.47%‬
Return on Assets
‪-7.19%‬
Return on Equity
‪-8.66%‬
Ownership
Shares Outstanding
281.20M
Float
28.46M
Short % of Shares Outstanding
‪47.64%‬
Held by Insiders
‪89.92%‬
Held by Institutions
‪13.56%‬
Price stats
50-Day Avg
‪20.27‬
200-Day Avg
‪16.30‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 20.83‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MMED - MiniMed Group, Inc.
Peers - MMED - MiniMed Group, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - MMED - MiniMed Group, Inc.
About
MiniMed Group, Inc. is a medical technology company focused on diabetes management. MiniMed develops, manufactures, and markets a connected ecosystem of products and services that includes insulin pumps, continuous glucose monitors, smart insulin pens, consumables, and supporting software. Its offerings are designed…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
